Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 10Recruiting 5Active not recruiting 4Unknown 1

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Stomach Neoplasms 15Rectal Neoplasms 13Triple Negative Breast Neoplasms 10Neoplasm Metastasis 7Pancreatic Neoplasms 6Nasopharyngeal Carcinoma 6Colonic Neoplasms 6Neoplasms 4Gallbladder Neoplasms 4Cholangiocarcinoma 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Klatskin Tumor 2Esophageal Squamous Cell Carcinoma 2Colorectal Cancer Metastatic 2Clinical Stage I Gastric Cancer AJCC v8 2Biliary Tract Neoplasms 2Adenoma, Islet Cell 2Squamous Cell Carcinoma of Head and Neck 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1

Interventions

Oxaliplatin 8Fluorouracil 8Leucovorin 7Paclitaxel 5pembrolizumab 4Capecitabine 4Radiotherapy 3Radiation 3Nivolumab 3Cisplatin 3zimberelimab 2tislelizumab 2durvalumab 2Trastuzumab 2Taxes 2Levoleucovorin 2Irinotecan 2Docetaxel 2Carboplatin 2zanidatamab 1tucatinib 1trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1spartalizumab 1quemliclustat 1obinutuzumab 1naptumomab estafenatox 1lenvatinib 1futibatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma Of Esophagus × Capecitabine × Clear all
NCT05152147 2026-05-19

HERIZON-GEA-01

Jazz Pharmaceuticals

Phase 3 Active not recruiting
920 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

NCT05568095 2026-05-08

STAR-221

Arcus Biosciences, Inc.

Phase 3 Active not recruiting
1,040 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT04248452 2026-05-05

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
314 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT04430738 2026-02-24

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

Seagen Inc.

Phase 2 Active not recruiting
40 enrolled 67 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡